Shawn Seong

Company: Shaperon

Job title: Chief Executive Officer

Seminars:

Spotlighting Phase II Clinical Data: Advancing GPCR19 Agonists for Patients with Atopic Dermatitis 9:00 am

Defining GPCR19’s role in inflammasome regulation through foundational immunology insights Highlighting Phase II studies supporting GPCR19-targeting strategies for modulating immune pathways in atopic dermatitis Uncovering the therapeutic potential of GPCR19 agonists across inflammatory skin conditions including diabetic ulcers, acne, etc.Read more

day: Conference Day Two AM